APA (7th ed.) Citation

Li, Y., Wang, P., Xu, J., Shi, X., Yin, T., & Teng, F. (2024). Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Li, Yikun, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, and Feifei Teng. Noninvasive Radiomic Biomarkers for Predicting Pseudoprogression and Hyperprogression in Patients with Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibition. Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Li, Yikun, et al. Noninvasive Radiomic Biomarkers for Predicting Pseudoprogression and Hyperprogression in Patients with Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibition. Taylor & Francis Group, 2024.